Sunregen

SunRegen is a biopharmaceutical company that develops drugs to treat neurodegenerative diseases, with a focus on innovative treatments for neurological, neuromuscular, and ophthalmic diseases. Their first product candidates target primary optical atrophy and are being evaluated for use in serious neurological/neuromuscular diseases such as ALS, Huntington's, Alzheimer\u2019s, and Parkinson\u2019s ...